155 related articles for article (PubMed ID: 9407953)
1. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.
Koike K; Kawabe T; Tanaka T; Toh S; Uchiumi T; Wada M; Akiyama S; Ono M; Kuwano M
Cancer Res; 1997 Dec; 57(24):5475-9. PubMed ID: 9407953
[TBL] [Abstract][Full Text] [Related]
2. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter.
Chen ZS; Kawabe T; Ono M; Aoki S; Sumizawa T; Furukawa T; Uchiumi T; Wada M; Kuwano M; Akiyama SI
Mol Pharmacol; 1999 Dec; 56(6):1219-28. PubMed ID: 10570049
[TBL] [Abstract][Full Text] [Related]
3. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2).
Kawabe T; Chen ZS; Wada M; Uchiumi T; Ono M; Akiyama S; Kuwano M
FEBS Lett; 1999 Aug; 456(2):327-31. PubMed ID: 10456333
[TBL] [Abstract][Full Text] [Related]
4. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.
Evers R; Kool M; van Deemter L; Janssen H; Calafat J; Oomen LC; Paulusma CC; Oude Elferink RP; Baas F; Schinkel AH; Borst P
J Clin Invest; 1998 Apr; 101(7):1310-9. PubMed ID: 9525973
[TBL] [Abstract][Full Text] [Related]
5. Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide.
Ban N; Takahashi Y; Takayama T; Kura T; Katahira T; Sakamaki S; Niitsu Y
Cancer Res; 1996 Aug; 56(15):3577-82. PubMed ID: 8758929
[TBL] [Abstract][Full Text] [Related]
6. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells.
Narasaki F; Oka M; Nakano R; Ikeda K; Fukuda M; Nakamura T; Soda H; Nakagawa M; Kuwano M; Kohno S
Biochem Biophys Res Commun; 1997 Nov; 240(3):606-11. PubMed ID: 9398612
[TBL] [Abstract][Full Text] [Related]
7. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?
Borst P; Kool M; Evers R
Semin Cancer Biol; 1997 Jun; 8(3):205-13. PubMed ID: 9441949
[TBL] [Abstract][Full Text] [Related]
8. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.
Paulusma CC; van Geer MA; Evers R; Heijn M; Ottenhoff R; Borst P; Oude Elferink RP
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):393-401. PubMed ID: 10024515
[TBL] [Abstract][Full Text] [Related]
9. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
Kool M; de Haas M; Scheffer GL; Scheper RJ; van Eijk MJ; Juijn JA; Baas F; Borst P
Cancer Res; 1997 Aug; 57(16):3537-47. PubMed ID: 9270026
[TBL] [Abstract][Full Text] [Related]
10. Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter.
Lee K; Belinsky MG; Bell DW; Testa JR; Kruh GD
Cancer Res; 1998 Jul; 58(13):2741-7. PubMed ID: 9661885
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver.
Ito K; Suzuki H; Hirohashi T; Kume K; Shimizu T; Sugiyama Y
J Biol Chem; 1998 Jan; 273(3):1684-8. PubMed ID: 9430713
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.
Kotoh S; Naito S; Yokomizo A; Kumazawa J; Asakuno K; Kohno K; Kuwano M
Cancer Res; 1994 Jun; 54(12):3248-52. PubMed ID: 8205547
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms for resistance to anticancer agents and the reversal of the resistance].
Akiyama S; Chen ZS; Kitazono M; Sumizawa T; Furukawa T; Aikou T
Hum Cell; 1999 Sep; 12(3):95-102. PubMed ID: 10695015
[TBL] [Abstract][Full Text] [Related]
15. Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.
Oguri T; Fujiwara Y; Isobe T; Katoh O; Watanabe H; Yamakido M
Br J Cancer; 1998 Apr; 77(7):1089-96. PubMed ID: 9569044
[TBL] [Abstract][Full Text] [Related]
16. Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior.
Matsunaga T; Shirasawa H; Hishiki T; Enomoto H; Kouchi K; Ohtsuka Y; Iwai J; Yoshida H; Tanabe M; Kobayashi S; Asano T; Etoh T; Nishi Y; Ohnuma N
Jpn J Cancer Res; 1998 Dec; 89(12):1276-83. PubMed ID: 10081488
[TBL] [Abstract][Full Text] [Related]
17. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.
Taniguchi K; Wada M; Kohno K; Nakamura T; Kawabe T; Kawakami M; Kagotani K; Okumura K; Akiyama S; Kuwano M
Cancer Res; 1996 Sep; 56(18):4124-9. PubMed ID: 8797578
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells.
Lee K; Klein-Szanto AJ; Kruh GD
J Natl Cancer Inst; 2000 Dec; 92(23):1934-40. PubMed ID: 11106685
[TBL] [Abstract][Full Text] [Related]
19. Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins.
Belinsky MG; Bain LJ; Balsara BB; Testa JR; Kruh GD
J Natl Cancer Inst; 1998 Nov; 90(22):1735-41. PubMed ID: 9827529
[TBL] [Abstract][Full Text] [Related]
20. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents.
Zeng H; Bain LJ; Belinsky MG; Kruh GD
Cancer Res; 1999 Dec; 59(23):5964-7. PubMed ID: 10606242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
